Differential effect of dehydroepiandrosterone and its steroid precursor pregnenolone against the behavioural deficits in CO-exposed mice.

@article{Maurice2000DifferentialEO,
  title={Differential effect of dehydroepiandrosterone and its steroid precursor pregnenolone against the behavioural deficits in CO-exposed mice.},
  author={Tangui Maurice and V L Phan and Françoise Sandillon and Alexandre Urani},
  journal={European journal of pharmacology},
  year={2000},
  volume={390 1-2},
  pages={
          145-55
        }
}

Antiamnesic and Neuroprotective Effects of Donepezil against Learning Impairments Induced in Mice by Exposure to Carbon Monoxide Gas

The results showed that donepezil is a potent antiamnesic and neuroprotective compound against the neurodegeneration induced by excitotoxic insult, and its pharmacological actions as both an acetylcholinesterase inhibitor and σ1 receptor agonist contribute to its marked efficacy.

The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects.

The data demonstrating that the sigma1 receptor binds neurosteroids in physiological conditions will be reviewed and the physiological relevance of this interaction will be analyzed and the impact on physiopathological outcomes in memory and drug addiction will be illustrated.

Anti-amnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide (CO)

Results showed that donepezil is a potent anti-amnesic and neuroprotective compound against the neurodegeneration induced by excitotoxic insult and its pharmacological actions as both an acetylcholinesterase inhibitor and σ 1 receptor agonist contribute to its marked efficacy.

The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats.

Results can be interpreted to demonstrate that after a 7-day delay, the chronic administration of DHEAS to injured rats significantly improves behavioral recovery on both sensorimotor and cognitive tasks.

Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer's Disease.

Despite mixed results, the findings of various preclinical studies are generally supportive of the involvement of DHEA and DHEAS in the pathophysiology of Alzheimer's disease, showing some promise for potential benefits of these neurosteroids in the prevention and treatment.

Differential involvement of the sigma1 (σ1) receptor in the anti‐amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse

The observations bring a molecular basis to the modulatory role of σ1 receptors in memory, and reveal that the anti‐amnesic action of neuroactive steroids may not similarly involve an interaction with ρ1 receptors.

References

SHOWING 1-10 OF 39 REFERENCES

Pregnenolone sulfate antagonizes dizocilpine amnesia: role for allopregnanolone

It is possible to suggest that the increase in the brain content of ALLO, rather than 5α-DHP, mediates the effect of PREG sulfate on dizocilpine- or CPPene-induced cognition deficit.

Modulation of steroidal levels by adrenalectomy/castration and inhibition of neurosteroid synthesis enzymes affect σ1 receptor‐mediated behaviour in mice

Investigation of the effects of inhibitors of key enzymes involved in neurosteroid synthesis in adrenalectomized/castrated mice revealed that, among neurosteroids, progesterone may be the main modulator of σ1 receptors.

Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors

The results suggest that some neuroactive steroids modulate the NMDA response via sigma receptors through the potentiation of dehydroepiandrosterone.

Effects of N-methyl-D-aspartate receptor antagonists on carbon monoxide-induced brain damage in mice.

It is clear that NMDA receptor/ion channel complex is involved in the mechanism of CO-induced neurodegeneration, and that glycine binding site antagonist as well as NMDA competitive and noncompetitive antagonists may have neuroprotective properties in neurological disorders associated with overactivation of NMDA receptors.

Neuroprotection by dehydroepiandrosterone-sulfate: role of an NFkappaB-like factor.

It is implied that age-related declines in the availability of DHEA-S could exacerbate neurotoxicity, and the data suggest that therapeutic gains may be obtained with pharmacological manipulation of kappaB-dependent transcription in neurons.

Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons.

The fractional open time (nPo) of single NMDA-activated channels was potentiated by PS in patch-clamp recordings using both the outside-out and cell-attached configurations, and the potentiation resulted from increases in the frequency of opening and in the mean channel open time.

Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity.

Results suggest that decreased DHEA levels may contribute significantly to the increased vulnerability of the aging or stressed human brain to such damage.

Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor.

The in vitro and in vivo neuroprotective effects of 3alpha5betaHS demonstrate that this steroid represents a new class of potentially useful therapeutic agents for the treatment of stroke and certain neurodegenerative diseases that involve over activation of NMDA receptors.